Cloud native software company SOPHiA GENETICS (NASDAQ:SOPH) has partnered with Strand Life Sciences, a bioinformatics and diagnostics provider, to deliver innovative solutions that will fuel the use of precision medicine globally.
The new collaboration will leverage the industry-leading strengths of both companies provide access to advanced genomic technologies, cutting-edge bioinformatics services and innovative diagnostic solutions.
The two companies will use their expertise in bioinformatics to expand the ability to accurately analyze key health data and facilitate the use of data-driven decision making globally.